Ajanta Pharma spurted 8.61% to Rs 1,148.30 at 15:33 IST on BSE after the company said its board will meet on 29 July 2013 to consider the proposal of issuing bonus shares.
The announcement was made during trading hours today, 18 July 2013.
Meanwhile, the S&P BSE Sensex was up 202.80 points, or 1.02%, to 20,151.53.
On BSE, 1.50 lakh shares were traded in the counter as against an average daily volume of 60,786 shares in the past one quarter.
The stock hit a high of Rs 1,155 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 1,020 so far during the day. The stock had hit a 52-week low of Rs 343 on 26 July 2012.
The stock had outperformed the market over the past one month till 17 July 2013, rising 19.71% compared with the Sensex's 3.22% rise. The scrip had outperformed the market in past one quarter, rising 54.68% as against Sensex's 6.50% rise.
The small-cap company has an equity capital of Rs 11.72 crore. Face value per share is Rs 5.
Ajanta Pharma added that the board will also consider the company's Q1 June 2013 results on 29 July 2013.
Net profit of Ajanta Pharma rose 14.79% to Rs 27.09 crore on 47.80% rise in net sales to Rs 249.21 crore in Q4 March 2013 over Q4 March 2012.
Ajanta Pharma is a specialty pharmaceutical company engaged in the development, manufacture and commercialisation of pharmaceutical products. It focuses on commercialising unique generic products and pioneering synergistic combination products in the therapeutic areas of anti- malarial, cardiology, dermatology, gastroenterology, musculoskeletal, ophthalmology and respiratory.
Powered by Capital Market - Live News
